Navigation Links
Da Vinci Robot Lawsuits Being Investigated by Bernstein Liebhard LLP, as New Study Raises More Questions About Purported Advantages of Robotic Surgery
Date:12/10/2013

New York, New York (PRWEB) December 10, 2013

As Bernstein Liebhard LLP continues to investigate potential da Vinci robot lawsuits (http://www.davincirobotlawsuithelp.com) on behalf of robot surgery patients who were allegedly injured by the da Vinci Surgical System, the Firm notes that yet another study has raised questions about the purported benefits of robot-assisted hysterectomy. According to a report from Internal Medicine News, research presented last month at the 43rd Annual AAGL Global Congress on Minimally Invasive Gynecology looked at data from 353 women who underwent a minimally invasive hysterectomy at a single U.S. facility between 2009 and 2012. Out of that group, 116 underwent traditional laparoscopic procedures, while 237 underwent a robotic hysterectomy. The authors of the study found that the women who underwent robot- assisted hysterectomy needed significantly more postoperative pain medication than did those who had a conventional laparoscopic hysterectomy.*

“This is just the most recent study to raise questions about the purported advantages of robotic surgery. It serves to remind that the risks and benefits of these procedures still need further evaluation,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm is currently offering free da Vinci lawsuit consultations to patients who allegedly suffered serious robotic surgery complications in procedures involving the da Vinci Surgical System.

Da Vinci Robot Lawsuits
According to Bernstein Liebhard LLP, the publication of this new study comes as concerns over the benefits, safety and costs of robotic surgery continue to mount. In February, a study published in the Journal of the American Medical Association found little evidence that robot-assisted hysterectomy offer
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. EVINCI results could lead to 75 percent reduction of invasive procedures for patients with suspected CAD
2. Da Vinci Surgery Robot Lawsuit Website Launched by Bernstein Leibhard LLP to Inform Public about Potential Da Vinci Surgery Complications
3. Da Vinci Robotic Procedure Offers a Surgical Solution for Endometriosis; Now Available at Women’s Excellence in Endometriosis in Oakland County, Michigan
4. Da Vinci Robotic Surgery Lawsuit News: Ohio Law Firm Investigates Da Vinci Robotic Surgery Complications as Settlement is Reached in Louisiana Da Vinci Robot Lawsuit
5. As Da Vinci Surgery Robot Lawsuits Mount, Marketing Claims Questioned in Wake of New Study, Alonso Krangle LLP Comments
6. Da Vinci Robotic Surgery Lawyers at Wright & Schulte LLC Disturbed by Allegations of Aggressive Marketing Tactics in Pending Da Vinci Robotic Surgery Lawsuit
7. New York Medical Malpractice Lawyer David Perecman Urges Surgical Patients to Question Use of da Vinci System Surgical Robot
8. Da Vinci Robotic Surgery Lawsuit: Parker Waichman LLP Responds to Doctor’s Testimony Alleging Intuitive Surgical’s Robotic Device Contributed to a Man’s Death
9. As Da Vinci Robot Lawsuits Mount, Bernstein Liebhard LLP Applauds Surgeon’s Call for More Stringent Robotic Surgery Training
10. Da Vinci Surgical Robot Lawsuit News: Rottenstein Law Group Comments on Testimony in Ongoing Robot Trial
11. Da Vinci Robotic Infographic Released by d’Oliveira & Associates Expresses Concerns over Surgical Device
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... [Brown University] Autism is no stranger to the ... African nation is access to clinical services, including reliable ... measure, for example, validated for use in Swahili, a ... study, however, researchers at Brown University and the University ... that they implemented at two sites in the country ...
(Date:9/30/2014)... passed in 2003 to slow the spiraling costs of ... Medicare patients has had no meaningful impact on cancer ... the Journal of Clinical Oncology published online ... to treat colorectal and lung cancers, and did not ... drugs following the implementation of the recent Medicare law ...
(Date:9/30/2014)... 2014 Dynamic health trends, changing ... in the Bread Production industry over the past ... moderate their consumption of a variety of industry ... shrunk the market for white loaf bread and ... by introducing more nutritious products to attract health-conscious ...
(Date:9/30/2014)... (FQHCs) granted new patient appointments to Medicaid beneficiaries ... primary care practices (non-FQHCs), in addition to charging ... new 10-state University of Pennsylvania study published this ... data from a previous "secret shopper" study conducted ... FQHCs community health clinics that receive federal ...
(Date:9/30/2014)... September 30, 2014(BRONX, NY)Medications are the leading cause of ... analysis of death certificates from 1999 to 2010, conducted ... and Albert Einstein College of Medicine of Yeshiva ... Journal of Allergy and Clinical Immunology , also ... was particularly high among older people and African-Americans and ...
Breaking Medicine News(10 mins):Health News:New diagnostic approach for autism in Tanzania 2Health News:New diagnostic approach for autism in Tanzania 3Health News:New diagnostic approach for autism in Tanzania 4Health News:Landmark Medicare law had little impact on reducing chemotherapy cost 2Health News:Bread Production in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Bread Production in the US Industry Market Research Report from IBISWorld Has Been Updated 3Health News:Medicaid and Uninsured patients obtain new patient appointments most easily at FQHCs 2Health News:Comprehensive Study of allergic deaths in US finds medications are main culprit 2
... Field, IRVING, Texas, Sept. 11 Over 90 ... solicitations during their training,and 80 percent received two dozen ... Merritt, Hawkins & Associates, a national physician,search firm based ... "Like blue chip athletes, new doctors are the ...
... 11 /PRNewswire-FirstCall/ - Haemacure Corporation (TSX,: HAE), ... plasma-derived protein products for commercialization,disclosed today the ... on the use of its proprietary lead ... preventing the formation of post-surgical,adhesions in a ...
... scoop, NEW YORK, Sept. 11 If ... impact a person,s body and skin, it,s a ... procedures last,year to improve their appearances. However, New ... can improve your appearance,without going under the knife!, ...
... will be of great interest to employers and employee benefit brokers ... grounbreaking wellness and health management tool designed to help control costs ... ... (PRWEB) September 11, 2008 -- U.S. Preventive Medicine, the leader in ...
... for the medical tourism industry. Working closely with medical tourism ... trip cancellation insurance products to meet the needs of the industry. ... ... Clements International develops unique suite of insurance solutions for the medical ...
... a traumatic injury can have serious and long-lasting ... the largest-ever U.S. study evaluating the impact of ... and Research Center, the University of Washington, and ... found that post-traumatic stress disorder and depression were ...
Cached Medicine News:Health News:Survey: New Doctors Receive Dozens of Job Solicitations 2Health News:Adhesion Prevention New Major Market Opportunity, Haemacure Confirms Effectiveness of its Fibrin Sealant in Second Preclinical Study in Adhesion Prevention in a Bleeding Model 2Health News:Adhesion Prevention New Major Market Opportunity, Haemacure Confirms Effectiveness of its Fibrin Sealant in Second Preclinical Study in Adhesion Prevention in a Bleeding Model 3Health News:Insider Secrets for Beautiful Skin 2Health News:U.S. Preventive Medicine Announces Nationwide Launch of The Prevention Plan 2Health News:U.S. Preventive Medicine Announces Nationwide Launch of The Prevention Plan 3Health News:U.S. Preventive Medicine Announces Nationwide Launch of The Prevention Plan 4Health News:Clements International Develops Insurance for Medical Tourism Industry 2Health News:National study finds post-traumatic stress disorder common among injured patients 2
(Date:9/30/2014)... 30, 2014  Alimera Sciences, Inc. (NASDAQ: ... the research, development and commercialization of prescription ophthalmic pharmaceuticals, ... advance from Hercules Technology Growth Capital, Inc. (NYSE: ... and final advance under the Loan and Security Agreement ... , Alimera Sciences Limited, entered into with Hercules ...
(Date:9/30/2014)... , Sept. 30, 2014 A study ... (OCT), offered a new look at the composition of ... how physicians understand and treat the disease, a leading ... at Baptist Health Lexington between September 2010 and May ... the Journal of the American College of Cardiology ...
(Date:9/30/2014)... Quebec , Sept. 30, 2014 Valeant ... TSX: VRX) today announced that the company,s ... Letter from the U.S. Food and Drug Administration (FDA) ... Company,s records with regards to Sculptra Aesthetic injectable, which ... Warning Letter pertains to the management of Valeant,s contract manufacturers ...
Breaking Medicine Technology:Alimera Sciences Receives $25 Million Advance from Hercules Technology Growth Capital 2New Imaging Tool May Allow Tailoring of Stroke Prevention to Each Patient 2Valeant Pharmaceuticals' Bridgewater Location Receives Warning Letter From FDA 2
... Jan. 31, 2012 Halozyme Therapeutics, Inc. (NASDAQ: ... Phase 1 proof-of-concept and local tolerability study of HTI-501 ... 8th World Congress of the International Academy of Cosmetic ... commencement of the Phase 2 portion of the clinical ...
... LAKES, N.J., Jan. 31, 2012 The Board of Directors of ... declared a quarterly dividend of 45 cents per common share, payable ... 2012. The indicated annual dividend rate is $1.80 per share. ... is a leading global medical technology company that develops, manufactures and ...
Cached Medicine Technology:HTI-501 Data Support Commencement of Phase 2 Portion of Clinical Trial 2HTI-501 Data Support Commencement of Phase 2 Portion of Clinical Trial 3